Co-Authors
This is a "connection" page, showing publications co-authored by ANNA MANDALAKAS and CHRISTOPH LANGE.
Connection Strength
3.654
-
Emerging bedaquiline-resistant tuberculosis. Lancet Microbe. 2023 12; 4(12):e964-e965.
Score: 0.969
-
Tuberculosis prevention: current strategies and future directions. Clin Microbiol Infect. 2023 Oct 31.
Score: 0.242
-
Tuberculosis incidence in foreign-born people residing in European countries in 2020. Euro Surveill. 2023 10; 28(42).
Score: 0.241
-
Correction: Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing. Genome Med. 2022 Sep 20; 14(1):107.
Score: 0.224
-
Tuberculosis prevention in children: a prospective community-based study in South Africa. Eur Respir J. 2021 04; 57(4).
Score: 0.203
-
Sorry for the delay. Clin Microbiol Infect. 2021 07; 27(7):941-943.
Score: 0.202
-
Perspective for Precision Medicine for Tuberculosis. Front Immunol. 2020; 11:566608.
Score: 0.196
-
Challenging the management of drug-resistant tuberculosis - Authors' reply. Lancet. 2020 03 07; 395(10226):783-784.
Score: 0.188
-
Management of drug-resistant tuberculosis. Lancet. 2019 09 14; 394(10202):953-966.
Score: 0.182
-
Editorial Commentary: 1, 2, 3 (Years)?????and You're Out: The End of a 123-year Historic Era. Clin Infect Dis. 2016 May 01; 62(9):1089-91.
Score: 0.142
-
Clinical Application of Interferon-? Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence. Pathog Immun. 2016; 1(2):308-329.
Score: 0.141
-
Performance of a stool-based quantitative PCR assay for the diagnosis of tuberculosis in adolescents and adults: a multinational, prospective diagnostic accuracy study. Lancet Microbe. 2024 Mar 07.
Score: 0.062
-
A stool based qPCR for the diagnosis of TB in children and people living with HIV in Uganda, Eswatini and Mozambique (Stool4TB): a protocol for a multicenter diagnostic evaluation. BMC Infect Dis. 2024 Feb 21; 24(1):233.
Score: 0.062
-
Tuberculosis screening in migrants to the EU/EEA and UK. Eur Respir J. 2023 11; 62(5).
Score: 0.061
-
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement. Lancet Infect Dis. 2023 04; 23(4):e122-e137.
Score: 0.058
-
Optimizing DNA Extraction from Pediatric Stool for Diagnosis of Tuberculosis and Use in Next-Generation Sequencing Applications. Microbiol Spectr. 2023 02 14; 11(1):e0226922.
Score: 0.057
-
Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes. Eur Respir J. 2022 09; 60(3).
Score: 0.056
-
Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis. Lancet Glob Health. 2022 09; 10(9):e1307-e1316.
Score: 0.056
-
Pathogenesis of tuberculosis: the 1930 L?beck disaster revisited. Eur Respir Rev. 2022 Jun 30; 31(164).
Score: 0.055
-
Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing. Genome Med. 2022 05 19; 14(1):52.
Score: 0.055
-
100 years of Mycobacterium bovis bacille Calmette-Gu?rin. Lancet Infect Dis. 2022 01; 22(1):e2-e12.
Score: 0.052
-
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model. Eur Respir J. 2021 09; 58(3).
Score: 0.052
-
Perspectives for systems biology in the management of tuberculosis. Eur Respir Rev. 2021 Jun 30; 30(160).
Score: 0.051
-
Tuberculosis endotypes to guide stratified host-directed therapy. Med (N Y). 2021 03 12; 2(3):217-232.
Score: 0.050